Insilica
Insilica is a bioinformatics company focused on accelerating informatics in public health, medicine, and chemistry through advanced data tools and AI. Their key products include Sysrev.com, an AI-guided document review platform that enables users to search, upload, and analyze documents with active learning for structured data creation, and BioBricks.ai, a bioinformatics data registry that simplifies importing and analyzing over 40 life science databases with common data science tools. The company has received multiple grants from NIH and NSF, highlighting its research credibility and innovation in chemical safety and toxicology data ecosystems. Insilica's technology integrates chemical informatics tools like RDKit and PySpark to enhance chemical reaction data analysis and machine learning model deployment, positioning it as a leader in life sciences informatics with a strong focus on data sharing, reuse, and accelerating chemical safety research.
Insilica
Insilica is a bioinformatics company focused on accelerating informatics in public health, medicine, and chemistry through advanced data tools and AI. Their key products include Sysrev.com, an AI-guided document review platform that enables users to search, upload, and analyze documents with active learning for structured data creation, and BioBricks.ai, a bioinformatics data registry that simplifies importing and analyzing over 40 life science databases with common data science tools. The company has received multiple grants from NIH and NSF, highlighting its research credibility and innovation in chemical safety and toxicology data ecosystems. Insilica's technology integrates chemical informatics tools like RDKit and PySpark to enhance chemical reaction data analysis and machine learning model deployment, positioning it as a leader in life sciences informatics with a strong focus on data sharing, reuse, and accelerating chemical safety research.
TL;DR
Founded: 2016
Focus: Bioinformatics for chemical safety, toxicology, and evidence synthesis
Core products: BioBricks (curated datasets), ToxIndex (automated regulatory-grade reports), Sysrev (human-in-the-loop review)
Funding: $2,335,861 (grant funding; last recorded 2025-05-02)
Backers: Funded via research grants from NIH and NSF
Company Overview
Problem Domain
Regulatory toxicology, chemical safety, and reproducible evidence synthesis for high-stakes decision-making.
Founded
2016
Industry
Biotechnology
Tech Stack
Funding Track Record
2335861 USD
Non-dilutive research grants (NIH, NSF, and other research grant support listed)
Investor Signal
“Backed by National Institutes of Health (NIH) and National Science Foundation (NSF) research grants”